Jochen Seufert

Summary

Affiliation: University Hospital
Country: Germany

Publications

  1. ncbi request reprint A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus
    Jochen Seufert
    Medizinische Poliklinik, University of Wurzburg, Wuerzburg, Germany
    Clin Ther 26:805-18. 2004
  2. ncbi request reprint A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control
    Jochen Seufert
    Division of Endocrinology and Diabetology, University of Freiburg, Freiburg, Germany
    Curr Med Res Opin 22:S39-48. 2006
  3. ncbi request reprint 2-year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with type 2 diabetes
    Jochen Seufert
    Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany
    Diabetes Res Clin Pract 79:453-60. 2008
  4. doi request reprint The backbone of oral glucose-lowering therapy: time for a paradigm shift?
    Jochen Seufert
    Division of Endocrinology and Diabetology, University Hospital of Freiburg, Freiburg, Germany
    Fundam Clin Pharmacol 23:651-67. 2009
  5. doi request reprint [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"]
    J Seufert
    Schwerpunkt Endokrinologie und Diabetologie, Abteilung Innere Medizin II, Universitatsklinikum Freiburg, Hugstetter Strasse 55, 79106 Freiburg
    Dtsch Med Wochenschr 133:1068-70. 2008
  6. pmc Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study
    Jochen Seufert
    Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg, Freiburg, Germany
    Vasc Health Risk Manag 9:711-7. 2013
  7. ncbi request reprint Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo
    Gunter Path
    Division of Endocrinology and Diabetology, Dept of Internal Medicine II, University Hospital of Freiburg, 79106 Freiburg, Germany
    Am J Physiol Endocrinol Metab 291:E1168-76. 2006
  8. ncbi request reprint Analysis of muscle microcirculation in advanced diabetes mellitus by contrast enhanced ultrasound
    D Duerschmied
    Department of Cardiology and Angiology, University Hospital of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany
    Diabetes Res Clin Pract 81:88-92. 2008
  9. ncbi request reprint Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes
    H J Kabitz
    Department of Pneumology, University Hospital Freiburg, Killianstrasse 5, 79106, Freiburg, Germany
    Diabetologia 51:191-7. 2008
  10. ncbi request reprint [Pharmaceutical therapy of diabetes mellitus type 2]
    K Laubner
    Abteilung Innere Medizin II, Schwerpunkt Endokrinologie und Diabetologie, Universitatsklinikum Freiburg, Freiburg, Deutschland
    Internist (Berl) 48:297-308; quiz 309. 2007

Collaborators

  • Peter Bramlage
  • Reinhard G Bretzel
  • D Duerschmied
  • H J Kabitz
  • K Laubner
  • Gunter Path
  • G Freund
  • P Maletzki
  • C Bode
  • C Hehrlein
  • F Sonntag
  • F Beuschlein
  • W Windisch
  • M Olschewski
  • D Walker
  • S Kaufmann
  • S Walterspacher
  • A Schwoerer
  • Catarina Limbert
  • Anne Opel
  • Lars Romfeld
  • Sigrun Hügl
  • Martin Gehlen
  • Anita Knoll
  • Mathias D Brendel
  • Veit Rothhammer
  • Xinjie Niu

Detail Information

Publications11

  1. ncbi request reprint A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus
    Jochen Seufert
    Medizinische Poliklinik, University of Wurzburg, Wuerzburg, Germany
    Clin Ther 26:805-18. 2004
    ..Although both types of agents improve glycemic control, their mechanisms of action and effects on metabolic processes differ...
  2. ncbi request reprint A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control
    Jochen Seufert
    Division of Endocrinology and Diabetology, University of Freiburg, Freiburg, Germany
    Curr Med Res Opin 22:S39-48. 2006
    ..A fixed-dose combination of pioglitazone (a thiazolidinedione) and metformin has been approved for use in the US (Actoplus met) and in Europe (Competact)...
  3. ncbi request reprint 2-year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with type 2 diabetes
    Jochen Seufert
    Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg, Hugstetter Strasse 55, 79106 Freiburg, Germany
    Diabetes Res Clin Pract 79:453-60. 2008
    ..We report the effectiveness of the thiazolidinedione, pioglitazone, as add-on medication to metformin or sulfonylurea in reducing post-load serum glucose levels, as assessed by 3-h oral glucose tolerance testing (OGTT)...
  4. doi request reprint The backbone of oral glucose-lowering therapy: time for a paradigm shift?
    Jochen Seufert
    Division of Endocrinology and Diabetology, University Hospital of Freiburg, Freiburg, Germany
    Fundam Clin Pharmacol 23:651-67. 2009
    ..A practical approach is taken, reflecting potential clinical situations in which therapeutic intervention is required...
  5. doi request reprint [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"]
    J Seufert
    Schwerpunkt Endokrinologie und Diabetologie, Abteilung Innere Medizin II, Universitatsklinikum Freiburg, Hugstetter Strasse 55, 79106 Freiburg
    Dtsch Med Wochenschr 133:1068-70. 2008
  6. pmc Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study
    Jochen Seufert
    Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg, Freiburg, Germany
    Vasc Health Risk Manag 9:711-7. 2013
    ..Therefore, the aim of this study was to analyze blood glucose control, rates of hypoglycemia and body weight in a large cohort of patients with type 2 diabetes treated with this combination therapy in real practice...
  7. ncbi request reprint Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo
    Gunter Path
    Division of Endocrinology and Diabetology, Dept of Internal Medicine II, University Hospital of Freiburg, 79106 Freiburg, Germany
    Am J Physiol Endocrinol Metab 291:E1168-76. 2006
    ..These results establish p8 as a novel molecular mediator of glucose-induced pancreatic beta-cell expansion in vitro and in vivo and support the notion of existing beta-cell replication in the adult organism...
  8. ncbi request reprint Analysis of muscle microcirculation in advanced diabetes mellitus by contrast enhanced ultrasound
    D Duerschmied
    Department of Cardiology and Angiology, University Hospital of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany
    Diabetes Res Clin Pract 81:88-92. 2008
    ..However, this approach was not suitable to assess microangiopathy of skeletal muscle, a major contributor to PAD in diabetic patients. We hypothesized that an optimized methodology would detect impaired microcirculation...
  9. ncbi request reprint Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes
    H J Kabitz
    Department of Pneumology, University Hospital Freiburg, Killianstrasse 5, 79106, Freiburg, Germany
    Diabetologia 51:191-7. 2008
    ..However, data on respiratory neuromuscular involvement in diabetes are lacking. This study therefore aimed to assess respiratory neuromuscular function related to diabetic polyneuropathy in patients with type 2 diabetes...
  10. ncbi request reprint [Pharmaceutical therapy of diabetes mellitus type 2]
    K Laubner
    Abteilung Innere Medizin II, Schwerpunkt Endokrinologie und Diabetologie, Universitatsklinikum Freiburg, Freiburg, Deutschland
    Internist (Berl) 48:297-308; quiz 309. 2007
    ..5%, insulin therapy is required either in combination with OADs as a bedtime regimen or as intensive insulin therapy using both basal and short-term acting insulins...
  11. ncbi request reprint Leptin effects on pancreatic beta-cell gene expression and function
    Jochen Seufert
    Division of Metabolism, Medizinische Poliklinik, University of Wuerzburg, Wuerzburg, Germany
    Diabetes 53:S152-8. 2004
    ..This leptin resistance at the level of the pancreatic beta-cell may contribute to dysregulation of the adipo-insular axis and promote the development of hyperinsulinemia and manifest type 2 diabetes in overweight patients...